Covid-19: why vaccine mistrust is growing

A vaccine for covid-19 could be rolled out before the end of the year. But a worrying rise in mistrust of vaccines threatens its effectiveness. Now & Next is a series from The Economist Films: https://films.economist.com/nowandnext/

Further content:

Find The Economist’s most recent coverage of covid-19 here: https://econ.st/3iwmMMH

Sign up to The Economist’s daily newsletter to keep up to date with our latest covid-19 analysis: https://econ.st/2Ckne0X

The immense promise of the new covid-19 vaccine, and the challenges still to come: https://econ.st/36EgZAd

Why an effective covid-19 vaccine is a turning point in the pandemic: https://econ.st/3kJfJRr

Read more about Pfizer’s and BioNTech’s vaccine: https://econ.st/3pyBvem

A second, better, vaccine against covid-19 arrives—read about Moderna’s vaccine: https://econ.st/3kEfOpE

Rich countries have grabbed half of projected covid-19 vaccine supply: https://econ.st/3nveNSm

Daily chart: One in three people want preferential access to a covid-19 vaccine: https://econ.st/2IyoYah

How pandemic fears are boosting demand for trustworthy news: https://econ.st/2UzCMU7

Super fast tests for covid-19 are coming: https://econ.st/32S1Ie5

How the quest for a vaccine could restore faith in big pharma: https://econ.st/32RSRJn